The absence of TRP53 causes a reduction in Zmat3 expression in a range of human carcinomas (e.g., breast, lung) and high levels of Zmat3 expression in malignant cells predict increased patient survival in certain cancers [6]. Here, ZMAT3 is linked to carcinoma.